His notable contributions have significantly advanced our understanding of biological product purification, often through collaborations with industry leaders. He has authored over 100 peer-reviewed journal articles, many of which involve fruitful partnerships with esteemed institutions in Thailand, India, and the USA. Currently, he oversees 15 doctoral and postdoctoral projects. One particularly impactful project led to the creation of Puridify, a nanofiber adsorption technology company now owned by Cytiva.
As the academic lead for the UCL-Cytiva Centre of Excellence, Daniel is at the forefront of pioneering efforts in bioprocessing. His current focus involves the development of cell-free/enzymatic manufacturing technologies, aimed at facilitating personalised cell and gene therapies.